These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7219643)

  • 21. Calcium and phosphorus in diet therapy of uremia.
    Schoolwerth AC; Engle JE
    J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Grenda R; Qiu P; Restaino I; Wojtak A; Paredes A; Benador N; Melnick JZ; Williams LA; Salusky IB
    Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal osteodystrophy--more than a mere bone disease].
    Saha H
    Duodecim; 2001; 117(21):2181-7. PubMed ID: 12184205
    [No Abstract]   [Full Text] [Related]  

  • 24. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients.
    Pizzarelli F; Zoccali C; Ciccarelli C; Maggiore Q; Bonucci E; Ballanti P
    Nephron; 1982; 32(1):93-4. PubMed ID: 7177287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid dysfunction end stage renal disease.
    DiTella PJ; Lang GR
    Otolaryngol Clin North Am; 1980 Feb; 13(1):193-201. PubMed ID: 7367004
    [No Abstract]   [Full Text] [Related]  

  • 27. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T; Horiike S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disordered divalent ion metabolism in kidney disease: comments on pathogenesis and treatment.
    Kleeman CR; Better OS
    Kidney Int; 1973 Aug; 4(2):73-9. PubMed ID: 4364428
    [No Abstract]   [Full Text] [Related]  

  • 29. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
    Fehr T; Garzoni D; Staub T; Binet I; Wüthrich RP
    Kidney Blood Press Res; 2006; 29(3):175-81. PubMed ID: 16931896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total parathyroidectomy and autotransplantation of parathyroid tissue for renal hyperparathyroidism. A one- to six-year follow-up.
    Rothmund M; Wagner PK
    Ann Surg; 1983 Jan; 197(1):7-16. PubMed ID: 6848057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal osteodystrophy and vitamin D derivatives: cellular mechanisms of hyperparathyroidism in uremia.
    Fukagawa M; Kurokawa K
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():96-9. PubMed ID: 1338454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding and managing hyperphosphatemia in patients with chronic renal disease.
    Malluche HH; Monier-Faugere MC
    Clin Nephrol; 1999 Nov; 52(5):267-77. PubMed ID: 10584989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective analysis of coronary calcium in patients on dialysis undergoing a near-total parathyroidectomy.
    Daniel WT; Weber C; Bailey JA; Raggi P; Sharma J
    Surgery; 2013 Dec; 154(6):1315-21; discussion 1321-2. PubMed ID: 24238050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study of parathyroidectomy of secondary hyperparathyroidism in patients with chronic renal failure].
    Yamaguchi S; Yachiku S; Morikawa M; Okuyama M; Numata A; Inada F; Anzai T; Kobayashi T; Furuta K; Ishida H
    Hinyokika Kiyo; 1992 May; 38(5):541-7. PubMed ID: 1609662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The course of osteodystrophy in patients with chronic kidney failure on hemodialysis].
    Zemchenko AIu; Shostka GD
    Urol Nefrol (Mosk); 1993; (6):51-4. PubMed ID: 8160326
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of renal osteodystrophy in predialysis patients.
    Sanchez CP; Goodman WG; Salusky IB
    Am J Med Sci; 1999 Jun; 317(6):398-404. PubMed ID: 10372840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease.
    Sanchez CP
    Semin Nephrol; 2001 Sep; 21(5):441-50. PubMed ID: 11559885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
    Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
    Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal osteodystrophy in children: the effect of hemodialysis and renal homotransplantation.
    Fine RN; Isaacson AS; Payne V; Grushkin CM
    J Pediatr; 1972 Feb; 80(2):243-9. PubMed ID: 4550451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.